Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatinLaura Poupon, Jérôme Busserolles, Youssef Aissouni et al.|Neuropharmacology|2018Cited by 70
Lysophosphatidylcholine 16:0 mediates chronic joint pain associated to rheumatic diseases through acid-sensing ion channel 3Florian Jacquot, Emmanuel Deval, Spiro Khoury et al.|Pain|2022Cited by 43
Lysophosphatidyl-choline 16:0 mediates persistent joint pain through Acid-Sensing Ion Channel 3: preclinical and clinical evidencesFlorian Jacquot, Emmanuel Deval, Spiro Khoury et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 3